Partial agonists for adenosine receptors

Pharmacochemistry Library

Volumn 24, Issue C, 1996, Pages 181-192

  IJzerman, A P ^a   van der Wenden, E M ^a   Roelen, H C P F ^a   Mathot R A A ^a   von Frijtag Drabbe Kunzel J K ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957047166     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(96)80015-8     Document Type: Article

References (52)

1. Jacobson M.A. In: Belardinelli L., and Pelleg A. (Eds). Adenosine and adenine nucleotides: from molecular biology to integrative physiology (1995), Kluwer, Boston 5-13
2. Jacobson K.A., Van Galen P.J.M., and Williams M. J Med Chem 35 (1992) 407-422
3. Kim H.O., Ji X., Siddiqi S.M., Olah M.E., Stiles G.L., and Jacobson K.A. J Med Chem 37 (1994) 3614-3621
4. Jacobson M.A., Chin J., Salvatore C.A., Johnson R.G., and Kostura M.J. Drug Dev. Res. 31 (1994) 282
5. Thiel M., Chouker A., Dieterich H.J., Brosig A., and Bardenheuer H.J. Drug Dev. Res. 31 (1994) 328
6. Mathôt R., Van Schaick E.A., Soudijn W., Breimer D.D., IJzerman A.P., and Danhof M. J. Pharmacol. Exp. Ther. 268 (1994) 616-624
7. Metz A.L., Dominick M.A., Suchanek G., and Gough A.W. Toxicol Pathol 19 (1991) 98-107
8. Ukena D., Olsson R.A., and Daly J.W. Can J Physiol Pharmacol 65 (1987) 365-376
9. Pirovano I.M., IJzerman A.P., Van Galen P.J.M., and Soudijn W. Eur J Pharmacol - Mol Pharmacol Sect 172 (1989) 185-193
10. Daly J.W., and Padgett W.L. Biochem Pharmacol 43 (1992) 1089-1093
11. Kenakin T.P. Pharmacologic analysis of drug-receptor interaction. 2nd ed. (1987), Raven, New York 455-459
12. Parsons W.J., and Stiles G.L. J Biol Chem 262 (1987) 841-847
13. Webb R.L., Sills M.A., Chovan J.P., Peppard J.V., and Francis J.E. J Pharm Exp Ther 267 (1993) 287-295
14. Barlow J.J., Main B.G., and Snow H.M. J Med Chem 24 (1981) 315-322
15. Kent R.S., De Lean A., and Lefkowitz R.J. Mol Pharmacol 17 (1980) 14-23
16. DeLean A., Stadel J.M., and Lefkowitz R.J. J Biol Chem 255 (1980) 7108-7117
17. Ehlert F.J. Mol Pharmacol 28 (1985) 410-421
18. Weiland G.A., Minneman K.P., and Molinoff P.B. Nature 281 (1979) 114-117
19. Weiland G.A., Minneman K.P., and Molinoff P.B. Mol Pharmacol 18 (1980) 341-347
20. Hitzemann R. TIPS 9 (1988) 408-411
21. Pert C.B., and Snyder S.H. Mol Pharmacol 10 (1974) 868-879
22. Horstman D.A., Brandon S., Wilson A.L., Guyer C.A., Cragoe Jr. E.J., and Limbird L.E. J Biol Chem 265 (1990) 21590-21595
23. Tsai B.S., and Lefkowitz R.J. Mol Pharmacol 14 (1978) 540-548
24. Bruns R.F., Daly J.W., and Snyder S.H. Proc Natl Acad Sci USA 77 (1980) 5547-5551
25. Goodman R.R., Cooper M.J., Gavish M., and Snyder S.H. Mol Pharmacol 21 (1982) 329-335
26. Yeung S.M.H., and Green R.D. J Biol Chem 258 (1983) 2334-2339
27. Lohse M.J., Lenschow V., and Schwabe U. Mol Pharmacol 26 (1984) 1-9
28. Bruns R.F., Fergus J.H., Badger E.W., Bristol J.A., Santay L.A., Hartman J.D., Hays S.J., and Huang C.C. Naunyn-Schmiedeberg's Arch Pharmacol 335 (1987) 59-63
29. Lohse M.J., Klotz K.N., Lindenborn-Fotinos J., Reddington M., Schwabe U., and Olsson R.A. Naunyn-Schmiedeberg's Arch Pharmacol 336 (1987) 204-210
30. Mathôt R., Van den Aarsen B.C.F.M., Von Frijtag Drabbe Künzel J.K., Danhof M., and IJzerman A.P. Naunyn-Schmiedeberg's Arch Pharmacol 350 (1994) 109-112
31. Murphy K.M.M., and Snyder S.H. Mol Pharmacol 22 (1982) 250-257
32. Borea P.A., Varani K., Malaguti V., and Gilli G. J Pharm Pharmacol 43 (1991) 866-868
33. Borea P.A., Varani K., Guerra L., Gilli P., and Gilli G. Mol Neuropharmacol 2 (1992) 273-281
34. Borea P.A., Dalpiaz A., Varani K., Guerra L., and Gilli G. Biochem Pharmacol 49 (1995) 461-469
35. IJzerman A.P., Van der Wenden E.M., Von Frijtag Drabbe Künzel J.K., Mathôt R., Danhof M., Borea P.A., and Varani K. Naunyn-Schmiedeberg's Arch Pharmacol 350 (1994) 638-645
36. Borea P.A., Varani K., Dalpiaz A., Capuzzo A., Fabbri E., and IJzerman A.P. Eur J Pharmacol - Mol Pharmacol Sect 267 (1994) 55-61
37. Goodman R.R., Cooper M.J., Gavish M., and Snyder S.H. Mol Pharmacol 21 (1982) 329-335
38. Green R.D. J Neurosci 4 (1984) 2472-2476
39. Stiles G.L. J Neurochem 51 (1988) 1592-1598
40. Linden J., Patel A., Earl C.Q., Craig R.H., and Daluge S.M. J Med Chem 31 (1988) 745-751
41. Ukena D., Padgett W.L., Hong O., Daly J.W., Daly D.T., and Olsson R.A. FEBS Lett 215 (1987) 203-208
42. IJzerman A.P., Van Galen P.J.M., and Jacobson K.A. Drug Design and Discovery 9 (1992) 49-67
43. IJzerman A.P., Van der Wenden E.M., Van Galen P.J.M., and Jacobson K.A. Eur J Pharmacol - Mol Pharm Sect 268 (1994) 95-104
44. Lohse M.J., Klotz K.-N., Diekmann E., Friedrich K., and Schwabe U. Eur J Pharmacol 156 (1988) 157-160
45. Van Galen P.J.M., Van Vlijmen H.W.T., IJzerman A.P., and Soudijn W. J Med Chem 33 (1990) 1708-1713
46. Van der Wenden E.M., IJzerman A.P., and Soudijn W. J Med Chem 35 (1992) 629-635
47. Van Galen P.J.M., IJzerman A.P., and Soudijn W. Nucleosides & Nucleotides 9 (1990) 275-291
48. Taylor M.D., Moos W.H., Hamilton H.W., Szotek D.S., Patt W.C., Badger E.W., Bristol J.A., Bruns R.F., Heffner T.G., and Mertz T.E. J Med Chem 29 (1986) 346-353
49. Nair V., Turner G.A., Buenger G.S., and Chamberlain S.D. J Org Chem 53 (1988) 3051-3057
50. Nair V., and Richardson S.G. J Org Chem 45 (1980) 3969-3974
51. Mathôt RAA, Van der Wenden EM, Soudijn W, IJzerman AP, Danhof M. Br J Pharmacol, in press
52. Danhof M., Mandema J.W., Hoogerkamp A., and Mathôt R. J Drug Metab Pharmacokin 18 (1993) 41-47